Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

lncRNA FOXD3‑AS1 promotes the progression of non‑small cell lung cancer by regulating the miR‑135a‑5p/CDK6 axis
Haiyan Guo, Shu-Fang Lin, Zhenyong Gan, et al.
Oncology Letters (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 10

Showing 10 citing articles:

Cell Cycle-Related lncRNAs as Innovative Targets to Advance Cancer Management
Xiao-Ru Liang, Yanfei Liu, Feng Chen, et al.
Cancer Management and Research (2023) Vol. Volume 15, pp. 547-561
Open Access | Times Cited: 13
Interactions between lncRNAs and cyclins/CDKs complexes; key players in determining cancer cell response to CDKs inhibitors
Bahaa Ibrahim Saeed, Abhinav Kumar, Enwa Felix Oghenemaro, et al.
Experimental Cell Research (2025) Vol. 445, Iss. 2, pp. 114406-114406
Closed Access
LncRNA FOXD3-AS1 modulates ER stress and epithelial barrier dysfunction in allergic rhinitis by destabilizing CHOP mRNA
Hao Zhang, Yaqiong Zhu, Chunping Yang, et al.
Cellular Signalling (2025), pp. 111737-111737
Closed Access
Beyond the genome: lncRNAs as regulators of the PI3K/AKT pathway in lung cancer
Waleed Hassan Almalki
Pathology - Research and Practice (2023) Vol. 251, pp. 154852-154852
Closed Access | Times Cited: 10
Emerging Roles and Mechanisms of lncRNA FOXD3-AS1 in Human Diseases
Qinfan Yao, Xiuyuan Zhang, Dajin Chen
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
Circular RNA CCT3 is a unique molecular marker in bladder cancer
Lin Luo, Qingzhi Xie, Yunchou Wu, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancer
Ailin Qu, Qian Wang, Qing Chang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Research on the mechanism of exosomes from different sources influencing the progression of lung cancer
Guangxian Mao, Jixian Liu
Environmental Toxicology (2024) Vol. 39, Iss. 8, pp. 4231-4248
Closed Access | Times Cited: 1
Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification
Xiaofeng Liu, Wenyan Chen, Yu Qi, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 5
Mechanism of lncRNA FOXD3-AS1/miR-338-3p in the malignant progression of nasopharyngeal carcinoma through ceRNA
Yuanming Li, Shuai Zhao, Baiye Chen
Cellular and Molecular Biology (2023) Vol. 69, Iss. 6, pp. 82-87
Open Access
Page 1

Scroll to top